tradingkey.logo


Kenvue Inc

KVUE

21.590USD

+0.150+0.70%
āļ›āļīāļ” 08/01, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
41.43BāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
39.23P/E TTM

āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ Kenvue Inc āļšāļĢāļīāļĐāļąāļ—
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
āļ‚āđ‰āļ­āļĄāļđāļĨāļšāļĢāļīāļĐāļąāļ—
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™KVUE
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—Kenvue Inc
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 04, 2023
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2022
āļ‹āļĩāļ­āļĩāđ‚āļ­Mr. Kirk L. Perry
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™22000
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒOrdinary Share
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“May 04
āļ—āļĩāđˆāļ­āļĒāļđāđˆ1 Kenvue Way
āđ€āļĄāļ·āļ­āļ‡SUMMIT
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒNYSE Consolidated
āļ›āļĢāļ°āđ€āļ—āļĻUnited States of America
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ07901
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ19088741200
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒhttps://www.kenvue.com
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™KVUE
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļMay 04, 2023
āļāđˆāļ­āļ•āļąāđ‰āļ‡āđ€āļĄāļ·āđˆāļ­2022
āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
27.46K
+124.86%
Mr. Matthew Orlando
Mr. Matthew Orlando
General Counsel
General Counsel
25.25K
+15.69%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
17.80K
+122.51%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļēāļ—āļīāļ•āļĒāđŒāļ—āļĩāđˆ 6 āļ.āļ„.
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Face and Body Care
673.38M
18.00%
Cough, Cold and Allergy
598.56M
16.00%
Other Self Care
598.56M
16.00%
Pain Care
486.33M
13.00%
Other Essential Health
374.10M
10.00%
Other
1.01B
27.00%
āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 16 āļž.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļĻāļļāļāļĢāđŒāļ—āļĩāđˆ 16 āļž.āļ„.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
The Vanguard Group, Inc.
12.15%
T. Rowe Price Associates, Inc.
10.85%
State Street Global Advisors (US)
6.26%
BlackRock Institutional Trust Company, N.A.
4.91%
MFS Investment Management
4.85%
Other
60.97%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Investment Advisor
56.49%
Investment Advisor/Hedge Fund
32.81%
Hedge Fund
4.38%
Research Firm
3.21%
Pension Fund
1.76%
Sovereign Wealth Fund
1.38%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 1 āļ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2025Q2
2088
1.95B
101.44%
-295.31M
2025Q1
2078
1.95B
101.47%
-298.35M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™î™Œ
āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
The Vanguard Group, Inc.
228.31M
11.89%
+10.60M
+4.87%
Mar 31, 2025
T. Rowe Price Associates, Inc.
208.36M
10.85%
-33.69M
-13.92%
Mar 31, 2025
State Street Global Advisors (US)
120.27M
6.26%
-134.23K
-0.11%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
94.32M
4.91%
+1.26M
+1.36%
Mar 31, 2025
MFS Investment Management
93.09M
4.85%
-771.33K
-0.82%
Mar 31, 2025
Fidelity Management & Research Company LLC
92.37M
4.81%
-13.82M
-13.02%
Mar 31, 2025
Wellington Management Company, LLP
61.47M
3.2%
-6.89M
-10.08%
Mar 31, 2025
Geode Capital Management, L.L.C.
48.40M
2.52%
+2.33M
+5.05%
Mar 31, 2025
Harris Associates L.P.
26.88M
1.4%
-4.64M
-14.71%
Mar 31, 2025
Charles Schwab Investment Management, Inc.
25.61M
1.33%
+633.46K
+2.54%
Mar 31, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡î™Œ
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: 3 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āļ—āļĩāđˆāđāļĨāđ‰āļ§
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: 3 āļŠāļąāđˆāļ§āđ‚āļĄāļ‡āļ—āļĩāđˆāđāļĨāđ‰āļ§
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Renaissance IPO ETF
9.18%
TBG Dividend Focus ETF
3.64%
American Century Focused Large Cap Value ETF
3.63%
Brookstone Value Stock ETF
3.54%
Cullen Enhanced Equity Income ETF
3.4%
TrueShares Low Volatility Equity Income ETF
3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.53%
VanEck Morningstar Wide Moat Value ETF
2.53%
ProShares Ultra Consumer Staples
2.52%
Consumer Staples Select Sector SPDR Fund
2.52%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
Renaissance IPO ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™9.18%
TBG Dividend Focus ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.64%
American Century Focused Large Cap Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.63%
Brookstone Value Stock ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.54%
Cullen Enhanced Equity Income ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.4%
TrueShares Low Volatility Equity Income ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™3.16%
Invesco S&P 500 Equal Weight Consumer Staples ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.53%
VanEck Morningstar Wide Moat Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.53%
ProShares Ultra Consumer Staples
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.52%
Consumer Staples Select Sector SPDR Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™2.52%
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 2.32B USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™î™Œ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™